Atlanta Consulting Group Advisors LLC Has $1.36 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Atlanta Consulting Group Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 11.3% during the fourth quarter, Holdings Channel reports. The firm owned 2,683 shares of the healthcare conglomerate’s stock after selling 342 shares during the period. Atlanta Consulting Group Advisors LLC’s holdings in UnitedHealth Group were worth $1,357,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of UNH. Howard Capital Management Group LLC bought a new position in shares of UnitedHealth Group in the third quarter worth $341,000. Principal Financial Group Inc. grew its position in UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock valued at $1,039,933,000 after acquiring an additional 180,479 shares during the last quarter. Meridian Investment Counsel Inc. bought a new position in UnitedHealth Group in the third quarter valued at about $208,000. Schear Investment Advisers LLC grew its position in UnitedHealth Group by 12.5% in the third quarter. Schear Investment Advisers LLC now owns 4,896 shares of the healthcare conglomerate’s stock valued at $2,863,000 after acquiring an additional 544 shares during the last quarter. Finally, BCGM Wealth Management LLC grew its position in UnitedHealth Group by 2.8% in the third quarter. BCGM Wealth Management LLC now owns 3,715 shares of the healthcare conglomerate’s stock valued at $2,172,000 after acquiring an additional 100 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.5 %

Shares of UnitedHealth Group stock opened at $488.52 on Monday. The stock has a fifty day simple moving average of $511.36 and a 200 day simple moving average of $549.80. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market capitalization of $446.85 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a $2.10 dividend. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analyst Ratings Changes

A number of research firms have issued reports on UNH. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.